🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

12+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 12 of 12 recruiting trials for “mucinous-adenocarcinoma-of-the-appendix

Phase 2RecruitingNCT07276360

Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda

👨‍⚕️ Solomon Kibudde, MBChB, MMed., Uganda Cancer Institute📍 1 site📅 Started Mar 2026View details ↗
Phase 1RecruitingNCT07454642

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

🏥 Avacta Life Sciences Ltd📍 2 sites📅 Started Mar 2026View details ↗
Phase 3RecruitingNCT07061977

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

👨‍⚕️ Jyoti S Mayadev, NRG Oncology📍 188 sites📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT07020117

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

🏥 Aktis Oncology, Inc.📍 9 sites📅 Started Aug 2025View details ↗
Phase 1, PHASE2RecruitingNCT05639972

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

👨‍⚕️ Christian S Hinrichs, MD, Rutgers Cancer Institute📍 2 sites📅 Started Aug 2025View details ↗
Phase 1RecruitingNCT07118176

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

👨‍⚕️ Jeremie Calais, UCLA / Jonsson Comprehensive Cancer Center📍 1 site📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT06654011

IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial

👨‍⚕️ Peng Wu, Ph.D, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China📍 2 sites📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06683846

Ivonescimab in the Treatment of Multiple Advanced Tumors

👨‍⚕️ Hongxia Wang, Doctor, Fudan University📍 1 site📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT05581121

PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer

🏥 Institut Claudius Regaud📍 30 sites📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT05686226

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

👨‍⚕️ Christian S Hinrichs, MD, Rutgers Cancer Institute📍 3 sites📅 Started Mar 2023View details ↗
NARecruitingNCT04907643

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

👨‍⚕️ Brennan Spiegel, MD, MSHS, Cedars-Sinai Medical Center📍 1 site📅 Started Oct 2021View details ↗
Phase 2RecruitingNCT03866382

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

👨‍⚕️ Andrea B Apolo, Alliance for Clinical Trials in Oncology📍 580 sites📅 Started May 2019View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →